# Antelope Surgical Solutions

Source: https://onco.cc/companies/antelope-surgical-solutions/  
OnCo record `antelope-surgical-solutions` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Antelope Surgical Solutions makes small molecules that stick to prostate cancer cells and glow during surgery, so the surgeon can see where the tumour ends; the same molecule is designed to carry a radioactive label for scans or treatment.

## Summary

Antelope Surgical Solutions, Inc. is a New York City clinical-stage radiopharmaceutical company founded in 2020, according to the company, developing multimodal small molecules for radioligand therapy, PET imaging and fluorescence-guided surgery. It states that it has built a GMP manufacturing facility with robotic high-throughput synthesis and received its first FDA IND clearance for its lead agent. AS1986NS is a fluorescent PSMA-targeting agent in a single-arm, blinded histopathology trial in men with prostate cancer (NCT06906471). Its first registered cancer trial, NCT06906471, was posted on ClinicalTrials.gov in April 2025.

## Fields

- Kind: Company
- Last checked: 2026-10-29
- Also known as: Antelope Surgical
- HQ: New York, NY
- Type: radiopharma
- Website: https://www.antelopesurgical.com/

## Notes

- Founding year, location and description from the company website, read on 29 October 2026. No financing round is recorded; the site's investor relations page was not read. The radioligand therapy and PET uses are the company's stated aims for its platform; the registered trial studies fluorescence-guided surgery only.

## Sources

- Official website: https://www.antelopesurgical.com/
- About: https://www.antelopesurgical.com/about
- ClinicalTrials.gov: fluorescent PSMA histopathology trial of AS1986NS (NCT06906471): https://clinicaltrials.gov/study/NCT06906471

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- fronts: [Imaging](https://onco.cc/fronts/imaging/), [Radiopharmaceuticals & Theranostics](https://onco.cc/fronts/radiopharma/), [Surgery & Interventional](https://onco.cc/fronts/surgery/)
- technologies: [Fluorescence-guided surgery](https://onco.cc/technologies/fluorescence-guided-surgery/), [PSMA PET](https://onco.cc/technologies/psma-pet/), [Radioligand therapy (beta emitters)](https://onco.cc/technologies/radioligand-therapy/)
- targets: [PSMA](https://onco.cc/targets/psma/)
- trials: [A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS](https://onco.cc/trials/nct06906471/)

---
JSON: https://onco.cc/api/v1/entities/antelope-surgical-solutions.json